In this chapter we will report on some of the most interesting advancements in mAbs and ADC-based therapeutics, with special focus on ACDs as a particular set of site-specific delivery systems. We anticipate that what we offered here will certainly spur the interest of scientists not yet active in this fascinating yet highly challenging field in the near future.
Site-specific drug delivery utilizing monoclonal antibodies
Domenico Marson;Maria Russi;Erik Laurini;Sabrina Pricl
2023-01-01
Abstract
In this chapter we will report on some of the most interesting advancements in mAbs and ADC-based therapeutics, with special focus on ACDs as a particular set of site-specific delivery systems. We anticipate that what we offered here will certainly spur the interest of scientists not yet active in this fascinating yet highly challenging field in the near future.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Antibodies_Chapt23.pdf
Accesso chiuso
Descrizione: Chapter23
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
827.26 kB
Formato
Adobe PDF
|
827.26 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
